GP Resources

GP Programme
Referral Guidelines
Continuing Medical Education for GPs

General Practitioners (“GP”) are an integral part of the healthcare system that supports our role in caring for patients and meeting their healthcare needs in our community. Hence, this resource portal serves to provide information and resources to support and keep our GPs updated on programmes and developments at Changi General Hospital and the Regional Health System (“RHS”).

GP Programmes These programmes help to support our partners in caring for our community.

Forms & Brochures This provide an easy access of the forms & brochures from the respective GP Programmes.

Useful Links & Resources A repository of useful links & resources for GPs.

Referral Guidelines CGH Specialties and Referrals at your fingertips to support and provide information relating to GP Referrals.

Latest News

Patient Care 针对癌症高风险者本地推出两旗舰研究评估癌症测试技术和筛查效用本地癌症发病率持续上升，癌症筛查率却始终偏低。为突破这一防癌瓶颈，本地医疗科研团队宣布启动两项计划，招募有患癌风险的公众参与，探讨如何借助新型检测技术与个性化方案，更早发现癌症隐患.

14 May 2026 | Lianhe Zaobao Read Story

Patient Care Singapore to trial multi-cancer early detection tests and targeted cancer screening A clinical study involving 1,000 people at higher risk of cancer due to genetic factors or pre-cancerous conditions will be carried out in the second half of 2026 to evaluate the use of popular multi-cancer early detection (MCED) tests.

14 May 2026 | The Straits Times Read Story

Announcements NCCS and NTU Singapore-led Cancer Prevention Research Institute Launches Studies to Evaluate Multi-Cancer Early Detection Tests and Tackle Metabolic Dysfunction-Linked Cancers in Singapore The Research Institute for Cancer Prevention, Screening and Early Detection (RISE), jointly led by the National Cancer Centre Singapore (NCCS) and Nanyang Technological University, Singapore (NTU Singapore), has announced the launch of two studies; one led by NCCS to evaluate multi-cancer early detection (MCED) tests and another led by the Lee Kong Chian School of Medicine (LKCMedicine) at NTU Singapore to develop targeted screening and prevention for metabolic dysfunction-linked cancers in Singapore.

13 May 2026 Read Story

View All